Tissue repair strategies: What we have learned from COVID-19 in the application of MSCs therapy

Coronavirus disease 2019 (COVID-19) infection evokes severe proinflammatory storm and pulmonary infection with the number of confirmed cases (more than 200 million) and mortality (5 million) continue to surge globally. A number of vaccines (e.g., Moderna, Pfizer, Johnson/Janssen and AstraZeneca vacc...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yiran E., Ajoolabady, Amir, Dhanasekaran, Muralikrishnan, Ren, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9242686/
https://www.ncbi.nlm.nih.gov/pubmed/35779816
http://dx.doi.org/10.1016/j.phrs.2022.106334

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9242686/
https://www.ncbi.nlm.nih.gov/pubmed/35779816
http://dx.doi.org/10.1016/j.phrs.2022.106334

Ejemplares similares